[1] Sukhorukov, V.S. and Nikolaeva, E.A. (2004) Violation of the Сellular Energy Exchange in Children. Ataes Medica Soft, Moscow, 79.
[2] Copeland, W. (2002) Mitochondrial DNA Methods and Protocols. Methods in Molecular Biology, 197, 401.
[3] Weissig, V. and Edeas, M. (2015) Mitochondrial Medicine. Methods in Molecular Biology. Springer Science + Business Media, New York.
[4] Gvozdjáková, A. (2008) Mitochondrial Medicine. Mitochondrial Metabolism, Diseases, Diagnosis and Therapy. Springer Science + Business Media, B.V. Dordrecht, Netherlands.
[5] Koene, S. and Smeitink, J. (2011) Mitochondrial Medicine. Journal of Inherited Metabolic Disease, 34, 247-248.
http://dx.doi.org/10.1007/s10545-011-9292-x
[6] Dorey, E. (2014) Mitochondrial Medicine. Nature Biotechnology, 32, 300.
http://dx.doi.org/10.1038/nbt0414-300a
[7] Sukhorukov, V.S. (2011) Studies of Mitochondrial Pathology. Publishing House “Medpraktika-M”, Moscow, 288.
[8] Scatena, R. (2012) Mitochondria and Drugs. Advances in Experimental Medicine and Biology, 942, 329-346.
http://dx.doi.org/10.1007/978-94-007-2869-1_15
[9] Parikh, S., Saneto, R., Falk, M., Anselm, I., Cohen, B. and Haas, R. (2009) A Modern Approach to the Treatment of Mitochondrial Disease. Current Treatment Options in Neurology, 11, 414-430.
http://dx.doi.org/10.1007/s11940-009-0046-0
[10] Andreazza, A. and Scola, G. (2015) Toxicology Studies—Cells, Drugs and Environment. In: Andreazza, A. and Scola, G., Eds., InTech, Rijeka, 62-63.
http://dx.doi.org/10.5772/58714
[11] Khuda-Bukhsh, A.R. (2014) Current Trends in High Dilution Research with Particular Reference to Gene Regulatory Hypothesis. The Nucleus, 57, 1, 3-17.
http://dx.doi.org/10.1007/s13237-014-0105-0
[12] Wälchli, C., Baumgartner, S. and Bastide, M. (2006) Effect of Low Doses and High Homeopathic Potencies in Normal and Cancerous Human Lymphocytes: An in Vitro Isopathic Study. The Journal of Alternative and Complementary Medicine, 12, 421-427.
[13] Lenger, K., Bajpai, R. and Spielmann, M. (2014) Identification of Unknown Homeopathic Remedies by Delayed Luminescence. Cell Biochemistry and Biophysics, 68, 321-334.
http://dx.doi.org/10.1007/s12013-013-9712-7
[14] Ezz, H. and Elkala, S. (2015) Ultra-Low-Dose Naloxone Added to Fentanyl and Lidocaine for Peribulbar Anesthesia: A Randomized Controlled Trial. Egyptian Journal of Anesthesia, 31, 161-165.
http://dx.doi.org/10.1016/j.egja.2014.12.005
[15] Yovell, Y., Bar, G., Mashiah, M., Baruch, Y. and Briskman, I. (2015) Ultra-Low-Dose Buprenorphine as a Time-Limited Treatment for Severe Suicidal Ideation: A Randomized Controlled Trial. The American Journal of Psychiatry, 15, 231-241
http://dx.doi.org/10.1176/appi.ajp.2015.15040535
[16] Thompson, T. and Weiss, M. (2006) Homeopathy—What Are the Active Ingredients? An Exploratory Study Using the UK Medical Research Council’s Framework for the Evaluation of Complex Interventions. BMC Complementary and Alternative Medicine, 12, 6-37.
http://dx.doi.org/10.1186/1472-6882-6-37
[17] Winchester, R.J. and Ross, G. (1976) Methods for Enumerating Lymphocyte Populations in Manual of Clinical Immunology. In: Rose, N.R. and Friedman, H., Eds., American Society for Microbiology, Washington DC, 64-76.
[18] Burlakova, E.B., Conrad, A.A. and Maltseva, E.L. (2003) Ultralow Doses Action of Biologically Active Substances and Low-Intensity Physical Factors. Chemical Physics, 22, 21-40.
[19] Yagoda, A.V. and Lokteva, N.A. (2005) Clinical Cytochemistry. SiGMA, Stavropol, 485.
[20] Lapach, S.N., Chubenko, A.V. and Babich, P.N. (2001) Statistical Methods in Biomedical Research Using Excel. 2nd Edition, MORION, Kyiv, 196.